Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: Q4Q6T1
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 4 |
GO:0003723 | RNA binding | 4 | 4 |
GO:0005488 | binding | 1 | 11 |
GO:0043167 | ion binding | 2 | 11 |
GO:0043169 | cation binding | 3 | 11 |
GO:0046872 | metal ion binding | 4 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 4 |
GO:1901363 | heterocyclic compound binding | 2 | 4 |
GO:0003729 | mRNA binding | 5 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 244 | 248 | PF00656 | 0.676 |
CLV_MEL_PAP_1 | 50 | 56 | PF00089 | 0.708 |
CLV_NRD_NRD_1 | 164 | 166 | PF00675 | 0.577 |
CLV_NRD_NRD_1 | 198 | 200 | PF00675 | 0.576 |
CLV_PCSK_KEX2_1 | 164 | 166 | PF00082 | 0.614 |
CLV_PCSK_KEX2_1 | 52 | 54 | PF00082 | 0.724 |
CLV_PCSK_PC1ET2_1 | 52 | 54 | PF00082 | 0.724 |
CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.557 |
CLV_PCSK_SKI1_1 | 189 | 193 | PF00082 | 0.507 |
CLV_PCSK_SKI1_1 | 209 | 213 | PF00082 | 0.282 |
CLV_Separin_Metazoa | 259 | 263 | PF03568 | 0.571 |
DEG_SPOP_SBC_1 | 238 | 242 | PF00917 | 0.733 |
DOC_CYCLIN_yCln2_LP_2 | 89 | 95 | PF00134 | 0.589 |
DOC_MAPK_MEF2A_6 | 146 | 153 | PF00069 | 0.486 |
DOC_PP2B_LxvP_1 | 89 | 92 | PF13499 | 0.518 |
DOC_USP7_MATH_1 | 201 | 205 | PF00917 | 0.628 |
DOC_USP7_MATH_1 | 238 | 242 | PF00917 | 0.728 |
DOC_WW_Pin1_4 | 105 | 110 | PF00397 | 0.558 |
DOC_WW_Pin1_4 | 13 | 18 | PF00397 | 0.636 |
DOC_WW_Pin1_4 | 202 | 207 | PF00397 | 0.568 |
DOC_WW_Pin1_4 | 21 | 26 | PF00397 | 0.660 |
DOC_WW_Pin1_4 | 96 | 101 | PF00397 | 0.668 |
LIG_14-3-3_CanoR_1 | 116 | 120 | PF00244 | 0.733 |
LIG_14-3-3_CanoR_1 | 78 | 83 | PF00244 | 0.402 |
LIG_Actin_WH2_2 | 184 | 201 | PF00022 | 0.577 |
LIG_APCC_ABBA_1 | 149 | 154 | PF00400 | 0.485 |
LIG_deltaCOP1_diTrp_1 | 213 | 222 | PF00928 | 0.591 |
LIG_eIF4E_1 | 129 | 135 | PF01652 | 0.585 |
LIG_eIF4E_1 | 22 | 28 | PF01652 | 0.727 |
LIG_FAT_LD_1 | 131 | 139 | PF03623 | 0.573 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.535 |
LIG_FHA_1 | 148 | 154 | PF00498 | 0.500 |
LIG_FHA_1 | 97 | 103 | PF00498 | 0.695 |
LIG_FHA_2 | 155 | 161 | PF00498 | 0.556 |
LIG_LIR_Nem_3 | 136 | 142 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 44 | 50 | PF02991 | 0.696 |
LIG_MYND_1 | 100 | 104 | PF01753 | 0.714 |
LIG_MYND_1 | 25 | 29 | PF01753 | 0.758 |
LIG_NRBOX | 130 | 136 | PF00104 | 0.581 |
LIG_PCNA_yPIPBox_3 | 156 | 165 | PF02747 | 0.479 |
LIG_SH2_PTP2 | 22 | 25 | PF00017 | 0.687 |
LIG_SH2_PTP2 | 47 | 50 | PF00017 | 0.719 |
LIG_SH2_STAT5 | 129 | 132 | PF00017 | 0.570 |
LIG_SH2_STAT5 | 22 | 25 | PF00017 | 0.657 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.719 |
LIG_SH3_3 | 117 | 123 | PF00018 | 0.389 |
LIG_SH3_3 | 45 | 51 | PF00018 | 0.736 |
LIG_SH3_3 | 89 | 95 | PF00018 | 0.658 |
LIG_SH3_3 | 98 | 104 | PF00018 | 0.702 |
LIG_UBA3_1 | 134 | 140 | PF00899 | 0.564 |
LIG_WRC_WIRS_1 | 219 | 224 | PF05994 | 0.604 |
MOD_CDK_SPxxK_3 | 109 | 116 | PF00069 | 0.685 |
MOD_CDK_SPxxK_3 | 202 | 209 | PF00069 | 0.588 |
MOD_CDK_SPxxK_3 | 96 | 103 | PF00069 | 0.718 |
MOD_CK1_1 | 108 | 114 | PF00069 | 0.629 |
MOD_CK1_1 | 9 | 15 | PF00069 | 0.636 |
MOD_CK2_1 | 154 | 160 | PF00069 | 0.561 |
MOD_CK2_1 | 201 | 207 | PF00069 | 0.523 |
MOD_CK2_1 | 218 | 224 | PF00069 | 0.438 |
MOD_CK2_1 | 245 | 251 | PF00069 | 0.659 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.602 |
MOD_GlcNHglycan | 247 | 250 | PF01048 | 0.714 |
MOD_GlcNHglycan | 253 | 256 | PF01048 | 0.672 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.616 |
MOD_GSK3_1 | 123 | 130 | PF00069 | 0.678 |
MOD_GSK3_1 | 214 | 221 | PF00069 | 0.493 |
MOD_GSK3_1 | 232 | 239 | PF00069 | 0.565 |
MOD_GSK3_1 | 56 | 63 | PF00069 | 0.507 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.659 |
MOD_N-GLC_1 | 155 | 160 | PF02516 | 0.485 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.616 |
MOD_NEK2_1 | 115 | 120 | PF00069 | 0.708 |
MOD_PIKK_1 | 115 | 121 | PF00454 | 0.708 |
MOD_PIKK_1 | 178 | 184 | PF00454 | 0.577 |
MOD_PIKK_1 | 214 | 220 | PF00454 | 0.553 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.722 |
MOD_Plk_1 | 155 | 161 | PF00069 | 0.483 |
MOD_Plk_4 | 23 | 29 | PF00069 | 0.696 |
MOD_ProDKin_1 | 105 | 111 | PF00069 | 0.552 |
MOD_ProDKin_1 | 13 | 19 | PF00069 | 0.637 |
MOD_ProDKin_1 | 202 | 208 | PF00069 | 0.567 |
MOD_ProDKin_1 | 21 | 27 | PF00069 | 0.662 |
MOD_ProDKin_1 | 96 | 102 | PF00069 | 0.671 |
MOD_SUMO_rev_2 | 173 | 181 | PF00179 | 0.597 |
MOD_SUMO_rev_2 | 203 | 211 | PF00179 | 0.569 |
TRG_DiLeu_BaEn_1 | 207 | 212 | PF01217 | 0.514 |
TRG_ENDOCYTIC_2 | 139 | 142 | PF00928 | 0.450 |
TRG_ENDOCYTIC_2 | 47 | 50 | PF00928 | 0.719 |
TRG_ER_diArg_1 | 163 | 165 | PF00400 | 0.606 |
TRG_Pf-PMV_PEXEL_1 | 175 | 179 | PF00026 | 0.563 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I028 | Leptomonas seymouri | 84% | 100% |
A0A1X0P164 | Trypanosomatidae | 40% | 93% |
A0A3Q8IFW3 | Leishmania donovani | 96% | 99% |
A0A3R7M044 | Trypanosoma rangeli | 42% | 100% |
A4HIU3 | Leishmania braziliensis | 89% | 100% |
A4I648 | Leishmania infantum | 96% | 99% |
C9ZRG8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 85% |
E9B1D1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
V5DNR8 | Trypanosoma cruzi | 39% | 100% |